Journal of Neural Transmission

, Volume 118, Issue 7, pp 1031–1041

Dietary inhibitors of monoamine oxidase A

Basic Neurosciences, Genetics and Immunology - Review Article


Inhibition of monoamine oxidase is one way to treat depression and anxiety. The information now available on the pharmacokinetics of flavonoids and of the components of tobacco prompted an exploration of whether a healthy diet (with or without smoking) provides active compounds in amounts sufficient to partially inhibit monoamine oxidase. A literature search was used to identify dietary monoamine oxidase inhibitors, the levels of these compounds in foods, the pharmacokinetics of the absorption and distribution, and tissue levels observed. An estimated daily intake and the expected tissue concentrations were compared with the measured efficacies of the compounds as inhibitors of monoamine oxidases. Norharman, harman and quercetin dietary presence, pharmacokinetics, and tissue levels were consistent with significant levels reaching neuronal monoamine oxidase from the diet or smoking; 1,2,3,4-tetrahydroisoquinoline, eugenol, 1-piperoylpiperidine, and coumarin were not. Quercetin was equipotent with norharman as a monoamine oxidase A inhibitor and its metabolite, isorhamnetin, also inhibits. Total quercetin was the highest of the compounds in the sample diet. Although bioavailability was variable depending on the source, a healthy diet contains amounts of quercetin that might give sufficient amounts in brain to induce, by monoamine oxidase A inhibition, a small decrease in neurotransmitter breakdown.


Antidepressant Harman Monoamine oxidase A Norharman Quercetin 



Blood–brain barrier


Forced swim test


Monoamine oxidase




  1. Andlauer W, Stumpf C, Hubert M, Rings A, Furst P (2003) Influence of cooking process on phenolic marker compounds of vegetables. Int J Vitam Nutr Res 73:152–159PubMedCrossRefGoogle Scholar
  2. Aricioglu F, Altunbas H (2003) Harmane induces anxiolysis and antidepressant-like effects in rats. Ann NY Acad Sci 1009:196–201PubMedCrossRefGoogle Scholar
  3. Bhutada P, Mundhada Y, Bansod K, Ubgade A, Quazi M, Umathe S, Mundhada D (2010) Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 34:955–960CrossRefGoogle Scholar
  4. Bieger J, Cermak R, Blank R, de Boer VC, Hollman PC, Kamphues J, Wolffram S (2008) Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138:1417–1420PubMedGoogle Scholar
  5. Bladt S, Wagner H (1994) Inhibition of MAO by fractions and constituents of hypericum extract. J Geriatr Psychiatry Neurol 7(Suppl 1):S57–S59PubMedCrossRefGoogle Scholar
  6. Bokkenheuser VD, Shackleton CH, Winter J (1987) Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J 248:953–956PubMedGoogle Scholar
  7. Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H (2000) Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med 66:3–6PubMedCrossRefGoogle Scholar
  8. Cermak R, Landgraf S, Wolffram S (2003) The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J Nutr 133:2802–2807PubMedGoogle Scholar
  9. Chen X, Yin OQ, Zuo Z, Chow MS (2005) Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 22:892–901PubMedCrossRefGoogle Scholar
  10. Chimenti F, Cottiglia F, Bonsignore L, Casu L, Casu M, Floris C, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F, Trombetta G, Loizzo A, Guarino I (2006) Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study. J Nat Prod 69:945–949PubMedCrossRefGoogle Scholar
  11. Choi JS, Bae JY, Kim DS, Li J, Kim JL, Lee YJ, Kang YH (2010) Dietary compound quercitrin dampens VEGF induction and PPARgamma activation in oxidized LDL-exposed murine macrophages: association with scavenger receptor CD36. J Agric Food Chem 58:1333–1341PubMedCrossRefGoogle Scholar
  12. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Galvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35:584–592PubMedCrossRefGoogle Scholar
  13. Crozier A, Lean MEJ, McDonald MS, Black C (1997) Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuce, and celery. J Agric Food Chem 45:590–595CrossRefGoogle Scholar
  14. Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 248:400–414PubMedGoogle Scholar
  15. de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135:1718–1725PubMedGoogle Scholar
  16. Dimpfel W (2009) Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action. Phytomedicine 16:287–294PubMedCrossRefGoogle Scholar
  17. Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138:1615–1621PubMedGoogle Scholar
  18. Erlund I (2004) Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 24:851–874CrossRefGoogle Scholar
  19. Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, Parantainen J, Aro A (2000) Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 56:545–553PubMedCrossRefGoogle Scholar
  20. Erlund I, Marniemi J, Hakala P, Alfthan G, Meririnne E, Aro A (2003) Consumption of black currants, lingonberries and bilberries increases serum quercetin concentrations. Eur J Clin Nutr 57:37–42PubMedCrossRefGoogle Scholar
  21. Farzin D, Mansouri N (2006) Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test. Eur Neuropsychopharmacol 16:324–328PubMedCrossRefGoogle Scholar
  22. Fekkes D, Bode WT (1993) Occurrence and partition of the beta-carboline norharman in rat organs. Life Sci 52:2045–2054PubMedCrossRefGoogle Scholar
  23. Fekkes D, Tuiten A, Bom I, Pepplinkhuizen L (2001) Pharmacokinetics of the β-carboline norharman in man. Life Sci 69:2113–2121PubMedCrossRefGoogle Scholar
  24. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996a) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733–736PubMedCrossRefGoogle Scholar
  25. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP (1996b) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065–14069PubMedCrossRefGoogle Scholar
  26. Guan Y, Louis ED, Zheng W (2001) Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. J Toxicol Environ Health A 64:645–660PubMedCrossRefGoogle Scholar
  27. Haleagrahara N, Radhakrishnan A, Lee N, Kumar P (2009) Flavonoid quercetin protects against swimming stress-induced changes in oxidative biomarkers in the hypothalamus of rats. Eur J Pharmacol 621:46–52PubMedCrossRefGoogle Scholar
  28. Han XH, Hong SS, Hwang JS, Lee MK, Hwang BY, Ro JS (2007) Monoamine oxidase inhibitory components from Cayratia japonica. Arch Pharm Res 30:13–17PubMedCrossRefGoogle Scholar
  29. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC (2007) A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45:2179–2205PubMedCrossRefGoogle Scholar
  30. Herraiz T (2004) Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit Contam 21:1041–1050PubMedCrossRefGoogle Scholar
  31. Herraiz T (2007) Identification and occurrence of beta-carboline alkaloids in raisins and inhibition of monoamine oxidase (MAO). J Agric Food Chem 55:8534–8540PubMedCrossRefGoogle Scholar
  32. Herraiz T, Chaparro C (2005) Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 326:378–386PubMedCrossRefGoogle Scholar
  33. Herraiz T, Chaparro C (2006a) Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants. J Chromatogr A 1120:237–243PubMedCrossRefGoogle Scholar
  34. Herraiz T, Chaparro C (2006b) Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee. Life Sci 78:795–802PubMedCrossRefGoogle Scholar
  35. Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H (2010) β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol 48:839–845PubMedCrossRefGoogle Scholar
  36. Hollman P, Katan M (1997) Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 51:305–310PubMedCrossRefGoogle Scholar
  37. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62:1276–1282PubMedGoogle Scholar
  38. Hollman PCH, van Trijp JMP, Buysman MNCP, v.d. Gaag MS, Mengelers MJB, de Vries JHM, Katan MB (1997a) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418:152–156PubMedCrossRefGoogle Scholar
  39. Hollman PCH, van Trijp JMP, Mengelers MJB, de Vries JHM, Katan MB (1997b) Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 114:139–140PubMedCrossRefGoogle Scholar
  40. Hossain CF, Okuyama E, Yamazaki M (1996) A new series of coumarin derivatives having monoamine oxidase inhibitory activity from Monascus anka. Chem Pharm Bull (Tokyo) 44:1535–1539Google Scholar
  41. Huebbe P, Wagner AE, Boesch-Saadatmandi C, Sellmer F, Wolffram S, Rimbach G (2010) Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer’s disease relevant genes in mice. Pharmacol Res 61:242–246PubMedCrossRefGoogle Scholar
  42. Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM, O’Reilly SL, Nicholson GC, Kotowicz MA, Berk M (2010) Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry 167:305–311PubMedCrossRefGoogle Scholar
  43. Kim H, Sablin SO, Ramsay RR (1997) Inhibition of monoamine oxidase A by β-carboline derivatives. Arch Biochem Biophys 337:137–142PubMedCrossRefGoogle Scholar
  44. Kohno M, Ohta S, Hirobe M (1986) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain. Biochem Biophys Res Commun 140:448–454PubMedCrossRefGoogle Scholar
  45. Kong LD, Cheng CHK, Tan RX (2004) Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J Ethnopharmacol 91:351–355PubMedCrossRefGoogle Scholar
  46. Kramer RE (1985) Antioxidants in clove. J Am Oil Chem Soc 62:111–113. doi:10.1007/BF02541505 CrossRefGoogle Scholar
  47. Kumaravelu P, Subramaniyam S, Dakshinamoorthy DP, Devaraj NS (1996) The antioxidant effect of eugenol on CCl4-induced erythrocyte damage in rats. J Nutr Biochem 7:23–28CrossRefGoogle Scholar
  48. Lee MH, Lin RD, Shen LY, Yang LL, Yen KY, Hou WC (2001) Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don. J Agric Food Chem 49:5551–5555PubMedCrossRefGoogle Scholar
  49. Lee SA, Hong SS, Han XH, Hwang JS, Oh GJ, Lee KS, Lee MK, Hwang BY, Ro JS (2005) Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chem Pharm Bull (Tokyo) 53:832–835CrossRefGoogle Scholar
  50. Li S, Wang C, Li W, Koike K, Nikaido T, Wang MW (2007) Antidepressant-like effects of piperine and its derivative, antiepilepsirine. J Asian Nat Prod Res 9:421–430PubMedCrossRefGoogle Scholar
  51. Lu J, Zheng Y, Luo L, Wu D, Sun D, Feng Y (2006) Quercetin reverses d-galactose induced neurotoxicity in mouse brain. Behav Brain Res 171:251–260PubMedCrossRefGoogle Scholar
  52. MacDonald IA, Bussard RG, Hutchison DM, Holdeman LV (1984) Rutin-induced beta-glucosidase activity in Streptococcus faecium VGH-1 and Streptococcus sp. strain FRP-17 isolated from human feces: formation of the mutagen, quercetin, from rutin. Appl Environ Microbiol 47:350–355PubMedGoogle Scholar
  53. Manach C, Texier O, Régérat F, Agullo G, Demigné C, Rémésy C (1996) Dietary quercetin is recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin. J Nutr Biochem 7:375–380CrossRefGoogle Scholar
  54. Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426:331–336PubMedCrossRefGoogle Scholar
  55. Matsubara K, Collins MA, Akane A, Ikebuchi J, Neafsey EJ, Kagawa M, Shiono H (1993) Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brain. Brain Res 610:90–96PubMedCrossRefGoogle Scholar
  56. Matsubara K, Gonda T, Sawada H, Uezono T, Kobayashi Y, Kawamura T, Ohtaki K, Kimura K, Akaike A (1998) Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson’s disease. J Neurochem 70:727–735PubMedCrossRefGoogle Scholar
  57. Milos M, Mastelic J, Jerkovic I (2000) Chemical composition and antioxidant effect of glycosidically bound volatile compounds from oregano (Origanum vulgare L. ssp. hirtum). Food Chem 71:79–83CrossRefGoogle Scholar
  58. Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, García-Sevilla JA (2005) High-affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain. Eur J Pharmacol 518:234–242PubMedCrossRefGoogle Scholar
  59. Moon YJ, Wang L, DiCenzo R, Morris ME (2008) Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 29:205–217PubMedCrossRefGoogle Scholar
  60. Morand C, Manach C, Crespy V, Remesy C (2000) Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Radic Res 33:667–676PubMedCrossRefGoogle Scholar
  61. Murota K, Terao J (2003) Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417:12–17PubMedCrossRefGoogle Scholar
  62. National Statistics Website (2006) National statistics smoking. Available at Accessed 11/17 2009
  63. Nemeth K, Plumb GW, Berrin JG, Juge N, Jacob R, Naim HY, Williamson G, Swallow DM, Kroon PA (2003) Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 42:29–42PubMedCrossRefGoogle Scholar
  64. Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T (1987) Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in Parkinsonian and normal human brains. Biochem Biophys Res Commun 144:1084–1089PubMedCrossRefGoogle Scholar
  65. Niwa T, Yoshizumi H, Tatematsu A, Matsuura S, Nagatsu T (1989) Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr B Biomed Sci Appl 493:347–352CrossRefGoogle Scholar
  66. Oddy WH, Robinson M, Ambrosini GL, O′Sullivan TA, de Klerk NH, Beilin LJ, Silburn SR, Zubrick SR, Stanley FJ (2009) The association between dietary patterns and mental health in early adolescence. Prev Med 49:39–44PubMedCrossRefGoogle Scholar
  67. Palomino O, Gómez-Serranillos MP, Slowing K, Carretero E, Villar A (2000) Study of polyphenols in grape berries by reversed-phase high-performance liquid chromatography. J Chromatogr A 870:449–451PubMedCrossRefGoogle Scholar
  68. Paulke A, Schubert-Zsilavecz M, Wurglics M (2006) Determination of St. John’s wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection. J Chromatogr B 832:109–113CrossRefGoogle Scholar
  69. Paulke A, Noldner M, Schubert-Zsilavecz M, Wurglics M (2008) St. John’s wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses. Pharmazie 63:296–302PubMedGoogle Scholar
  70. Pfau W, Skog K (2004) Exposure to β-carbolines norharman and harman. J Chromatogr B 802:115–126CrossRefGoogle Scholar
  71. Price KR, Prosser T, Richetin AMF, Rhodes MJC (1999) A comparison of the flavonol content and composition in dessert, cooking and cider-making apples; distribution within the fruit and effect of juicing. Food Chem 66:489–494CrossRefGoogle Scholar
  72. Ranka S, Gee JM, Biro L, Brett G, Saha S, Kroon P, Skinner J, Hart AR, Cassidy A, Rhodes M, Johnson IT (2008) Development of a food frequency questionnaire for the assessment of quercetin and naringenin intake. Eur J Clin Nutr 62(9):1131–1138. doi:10.1038/sj.ejcn.1602827 PubMedCrossRefGoogle Scholar
  73. Rommelspacher H, May T, Salewski B (1994) Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur J Pharmacol 252:51–59PubMedCrossRefGoogle Scholar
  74. Rommelspacher H, Meier-Henco M, Smolka M, Kloft C (2002) The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. Eur J Pharmacol 441:115–125PubMedCrossRefGoogle Scholar
  75. Saaby L, Rasmussen HB, Jäger AK (2009) MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull. J Ethnopharmacol 121:178–181PubMedCrossRefGoogle Scholar
  76. Sakakibara H, Yoshino S, Kawai Y, Terao J (2008) Antidepressant-like effect of onion (Allium cepa L.) powder in a rat behavioral model of depression. Biosci Biotechnol Biochem 72:94–100PubMedCrossRefGoogle Scholar
  77. Sanchez-Villegas A, Delgado-Rodriguez M, Alonso A, Schlatter J, Lahortiga F, Serra Majem L, Martinez-Gonzalez MA (2009) Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry 66:1090–1098PubMedCrossRefGoogle Scholar
  78. Sarris J, Schoendorfer N, Kavanagh DJ (2009) Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. Nutr Rev 67:125–131PubMedCrossRefGoogle Scholar
  79. Schulz HU, Schurer M, Bassler D, Weiser D (2005) Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers. Arzneimittelforschung 55:561–568PubMedGoogle Scholar
  80. Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PK, Coutts RT (2000) Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol 52:451–459PubMedCrossRefGoogle Scholar
  81. Sproll C, Ruge W, Andlauer C, Godelmann R, Lachenmeier DW (2008) HPLC analysis and safety assessment of coumarin in foods. Food Chem 109:462–469CrossRefGoogle Scholar
  82. Talhout R, Opperhuizen A, van Amsterdam JGC (2007) Role of acetaldehyde in tobacco smoke addiction. Eur Neuropsychopharmacol 17:627–636PubMedCrossRefGoogle Scholar
  83. Tao G, Irie Y, Li D, Keung WM (2005) Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity. Bioorg Med Chem 13:4777–4788PubMedCrossRefGoogle Scholar
  84. Thull U, Kneubühler S, Gaillard P, Carrupt P, Testa B, Altomare C, Carotti A, Jenner P, McNaught KSP (1995) Inhibition of monoamine oxidase by isoquinoline derivatives: qualitative and 3D-quantitative structure–activity relationships. Biochem Pharmacol 50:869–877PubMedCrossRefGoogle Scholar
  85. Totsuka Y, Ushiyama H, Ishihara J, Sinha R, Goto S, Sugimura T, Wakabayashi K (1999) Quantification of the co-mutagenic β-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett 143:139–143PubMedCrossRefGoogle Scholar
  86. USDA (2007) USDA database for the flavonoid content of selected foods. United States Department of Agriculture. Available via USDA Database for the Flavonoid Content of Selected Foods. Accessed September, 2010
  87. Walle T, Otake Y, Walle UK, Wilson FA (2000) Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J Nutr 130:2658–2661PubMedGoogle Scholar
  88. Waller AR, Chasseaud LF (1981) The metabolic fate of [14C]coumarin in baboons. Food Cosmet Toxicol 19:1–6PubMedCrossRefGoogle Scholar
  89. Wattanathorn J, Chonpathompikunlert P, Muchimapura S, Priprem A, Tankamnerdthai O (2008) Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol 46:3106–3110PubMedCrossRefGoogle Scholar
  90. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (2003) Interaction between flavonoids and the blood–brain barrier: in vitro studies. J Neurochem 85:180–192PubMedCrossRefGoogle Scholar
  91. Youdim KA, Shukitt-Hale B, Joseph JA (2004) Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37:1683–1693PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Biomedical Sciences Research ComplexUniversity of St AndrewsSt AndrewsUK

Personalised recommendations